BTG1 and thyroid gland carcinoma: BTG1 hypoexpression was reported to significantly correlate with aggressive features and worse prognosis of thyroid cancer (23), esophageal cancer (26), breast cancer (24), non-small cell lung cancer (29), and skin squamous carcinoma (30).